VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 514 filers reported holding VANECK VECTORS ETF TR in Q1 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,456,695 | -11.3% | 91,293 | -0.7% | 0.19% | -8.1% |
Q2 2023 | $2,768,916 | +4.2% | 91,960 | +12.0% | 0.21% | -1.4% |
Q1 2023 | $2,656,615 | +19.3% | 82,121 | +5.7% | 0.21% | +15.1% |
Q4 2022 | $2,227,713 | -2.3% | 77,729 | -17.7% | 0.19% | -9.3% |
Q3 2022 | $2,279,000 | -24.4% | 94,485 | -14.2% | 0.20% | -24.4% |
Q2 2022 | $3,015,000 | -25.4% | 110,111 | +4.5% | 0.27% | -11.1% |
Q1 2022 | $4,040,000 | +3.3% | 105,355 | -13.7% | 0.30% | +8.9% |
Q4 2021 | $3,911,000 | +48.9% | 122,118 | +37.0% | 0.28% | +36.6% |
Q3 2021 | $2,627,000 | -12.0% | 89,141 | +1.4% | 0.20% | -10.1% |
Q2 2021 | $2,986,000 | +9.9% | 87,876 | +5.1% | 0.23% | +2.7% |
Q1 2021 | $2,716,000 | -2.8% | 83,578 | +7.7% | 0.22% | -7.9% |
Q4 2020 | $2,795,000 | +22.7% | 77,595 | +33.4% | 0.24% | +8.6% |
Q3 2020 | $2,278,000 | +252.6% | 58,175 | +230.2% | 0.22% | +221.7% |
Q2 2020 | $646,000 | +215.1% | 17,620 | +151.7% | 0.07% | +228.6% |
Q4 2019 | $205,000 | – | 7,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |